HUTCHMED (China) Limited (HCM) News
Track canonical SquawkNews coverage tagged to HCM, HUTCHMED (China) Limited. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
HCM - HUTCHMED Reports 2026 Interim Results
HCM - HUTCHMED Reports 2026 Interim Results
EQUITY | Jul 30, 2026, 11:00 AM UTC
L
HUTCHMED Says China Grants Conditional Approval For ORPATHYS In MET-Amplified Gastric And Gastroesophageal Junction Cancer
HUTCHMED Says China Grants Conditional Approval For ORPATHYS In MET-Amplified Gastric And Gastroesophageal Junction Cancer
GEOPOLITICS | Jul 02, 2026, 08:46 AM UTC
M
HCM Presents Fanregratinib Data
HUTCHMED presents pivotal phase II data for fanregratinib in intrahepatic cholangiocarcinoma at ESMO Gastrointestinal Cancers Congress 2026
EQUITY | Jun 25, 2026, 12:30 AM UTC